These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33073544)

  • 21. Liver Microphysiological Systems for Predicting and Evaluating Drug Effects.
    Ribeiro AJS; Yang X; Patel V; Madabushi R; Strauss DG
    Clin Pharmacol Ther; 2019 Jul; 106(1):139-147. PubMed ID: 30993668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microfluidic Multitissue Platform for Advanced Embryotoxicity Testing In Vitro.
    Boos JA; Misun PM; Michlmayr A; Hierlemann A; Frey O
    Adv Sci (Weinh); 2019 Jul; 6(13):1900294. PubMed ID: 31380185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening.
    Skardal A; Devarasetty M; Forsythe S; Atala A; Soker S
    Biotechnol Bioeng; 2016 Sep; 113(9):2020-32. PubMed ID: 26888480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A thermoplastic microfluidic microphysiological system to recapitulate hepatic function and multicellular interactions.
    Bale SS; Manoppo A; Thompson R; Markoski A; Coppeta J; Cain B; Haroutunian N; Newlin V; Spencer A; Azizgolshani H; Lu M; Gosset J; Keegan P; Charest JL
    Biotechnol Bioeng; 2019 Dec; 116(12):3409-3420. PubMed ID: 30963546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promises, challenges and future directions of microCCAs.
    Esch MB; Sung JH; Shuler ML
    J Biotechnol; 2010 Jul; 148(1):64-9. PubMed ID: 20193719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atazanavir/ritonavir: a review of its use in HIV therapy.
    von Hentig N
    Drugs Today (Barc); 2008 Feb; 44(2):103-32. PubMed ID: 18389089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiologically-Based Pharmacokinetic Modeling for Optimal Dosage Prediction of Quinine Coadministered With Ritonavir-Boosted Lopinavir.
    Saeheng T; Na-Bangchang K; Siccardi M; Rajoli RKR; Karbwang J
    Clin Pharmacol Ther; 2020 May; 107(5):1209-1220. PubMed ID: 31721171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pumpless multi-organ-on-a-chip (MOC) combined with a pharmacokinetic-pharmacodynamic (PK-PD) model.
    Lee H; Kim DS; Ha SK; Choi I; Lee JM; Sung JH
    Biotechnol Bioeng; 2017 Feb; 114(2):432-443. PubMed ID: 27570096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addressing a vascular endothelium array with blood components using underlying microfluidic channels.
    Genes LI; V Tolan N; Hulvey MK; Martin RS; Spence DM
    Lab Chip; 2007 Oct; 7(10):1256-9. PubMed ID: 17896007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
    Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
    Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
    Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
    Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening.
    Wilmer MJ; Ng CP; Lanz HL; Vulto P; Suter-Dick L; Masereeuw R
    Trends Biotechnol; 2016 Feb; 34(2):156-170. PubMed ID: 26708346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver microphysiological platforms for drug metabolism applications.
    Kulsharova G; Kurmangaliyeva A
    Cell Prolif; 2021 Sep; 54(9):e13099. PubMed ID: 34291515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents.
    Maschmeyer I; Lorenz AK; Schimek K; Hasenberg T; Ramme AP; Hübner J; Lindner M; Drewell C; Bauer S; Thomas A; Sambo NS; Sonntag F; Lauster R; Marx U
    Lab Chip; 2015 Jun; 15(12):2688-99. PubMed ID: 25996126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Microfluidic Bioreactor for Toxicity Testing of Stem Cell Derived 3D Cardiac Bodies.
    Christoffersson J; Bergström G; Schwanke K; Kempf H; Zweigerdt R; Mandenius CF
    Methods Mol Biol; 2016; 1502():159-68. PubMed ID: 27052611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lopinavir/ritonavir: appraisal of its use in HIV therapy.
    von Hentig N
    Drugs Today (Barc); 2007 Apr; 43(4):221-47. PubMed ID: 17460785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-Based Assays on Microfluidics for Drug Screening.
    Liu X; Zheng W; Jiang X
    ACS Sens; 2019 Jun; 4(6):1465-1475. PubMed ID: 31074263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of body-on-a-chip devices in drug and toxicity studies.
    Esch MB; King TL; Shuler ML
    Annu Rev Biomed Eng; 2011 Aug; 13():55-72. PubMed ID: 21513459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience.
    van Heeswijk RP; Veldkamp A; Mulder JW; Meenhorst PL; Lange JM; Beijnen JH; Hoetelmans RM
    Antivir Ther; 2001 Dec; 6(4):201-29. PubMed ID: 11878403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.